Behavior problems and subtypes of attention-deficit hyperactivity disorder with comorbidities.

Area of Science:

• Child and Adolescent Psychiatry
• Neurodevelopmental Disorders
• Behavioral Science

Background:

• Attention-deficit hyperactivity disorder (ADHD) presents with distinct subtypes, inattentive (ADHD-I) and combined (ADHD-C).
• Comorbidities frequently co-occur with ADHD, potentially influencing symptom presentation and severity.
• Understanding the interplay between ADHD subtypes, comorbidities, and behavioral symptoms is crucial for effective clinical management.

Purpose of the Study:

• To investigate the relationship between Child Behavior Checklist (CBCL) symptoms and ADHD subtypes (ADHD-I, ADHD-C).
• To examine the impact of comorbidities on behavioral symptom severity across different ADHD subtypes.
• To determine if CBCL scales can differentiate ADHD patients with varying symptom severity.

Main Methods:

• 116 children diagnosed with ADHD were assessed using the Mini-International Neuropsychiatric Interview for ADHD subtypes and comorbidities.
• Participants were categorized into four groups based on ADHD subtype and presence/absence of comorbidities.
• Parent-completed Child Behavior Checklist (CBCL) data were analyzed to compare behavioral symptom severity across the four groups.

Main Results:

• Patients with ADHD-I and comorbidities exhibited higher Aggressive Behavior and Anxiety/Depression scores compared to ADHD-I without comorbidities.
• ADHD-C without comorbidities showed higher Aggressive Behavior scores than ADHD-I without comorbidities.
• ADHD-C with comorbidities displayed significantly higher scores across all six CBCL scales compared to ADHD-I without comorbidities, indicating a synergistic effect.

Conclusions:

• The combined subtype of ADHD (ADHD-C) with comorbidities has a synergistic effect on behavioral symptom severity.
• The Child Behavior Checklist (CBCL) is a valuable tool for physicians to identify and differentiate ADHD patients with more severe behavioral symptoms.
• Clinical attention to comorbidities in ADHD-C is essential for managing heightened behavioral challenges.